A growing number of Australians are putting their names forward to participate in clinical trials for medicines as the global race to find a vaccine or treatment for COVID-19 intensifies.
The trial has signed up 10,000 healthcare workers as participants, with two-thirds in Australia and the remainder in the Netherlands and Spain.Professor Andrew Davidson, medical director of the Melbourne Children's Trials Centre, said the trial recruited 100 participants in its first day. Australian startup HealthMatch, which matches applicants with trials, has also seen increased demand and has fielded 500 applications from Australians since the coronavirus hit. The startup has had to open up its platform for free to organisations conducting clinical trials for coronavirus.HealthMatch raised $6 million last year from venture capital funds, including Paul Bassat's Square Peg and Sydney-based Tempus Partners.
"We have built a technology that can screen patients and sign them up very efficiently for trials and more broadly it is really about providing more efficient recruitment and connecting," she said. "However, because Australia is recovering at a faster rate than other areas we are hearing Australia is going to be allocated more upcoming clinical trials."
However, what is the downside of these trials?
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: smh - 🏆 6. / 80 Read more »